The NRTSF stock collapsed to $2.50e-05 on market hours 07 Mar 2026, a one-day move of -99.97% versus the prior close of $0.08041094. This sharp fall made Nobilis Health Corp. (NRTSF) one of the top losers on the PNK exchange in the United States today. Volume remained thin at 657 shares, suggesting limited liquidity and potential corporate action or quotation adjustment behind the trade. We assess what drove this drop, the firm’s key metrics, and where the stock could move next.

Price action snapshot and trading facts

NRTSF stock traded intraday between a day low $0.000001 and day high $2.50e-05 on 07 Mar 2026. The one-day percent change measured -99.97%, with reported volume at 657 versus an average volume of 31,802. Market capitalization stands at $1,956 (USD) and shares outstanding total 78,250,465. The gap from the previous close of $0.08041094 indicates an extreme repricing event; confirm any corporate notices before trading.

Reasoning behind the collapse: likely drivers

No definitive market news is embedded in the quote data, but a drop of this size typically links to one of three causes: corporate action (reverse split, delisting, or suspension), reporting/filing issues, or a quotation error. For microcap healthcare firms like Nobilis Health Corp., regulatory filings and exchange notices often precede such moves. Traders should check official filings and OTC or issuer statements before attributing the decline to fundamentals.

Fundamentals and valuation metrics

Nobilis Health Corp. operates outpatient surgery centers in the Healthcare sector and shows mixed underlying metrics. Trailing EPS is 0.02 (USD) and book value per share is 2.54 (USD). Enterprise value is listed as $114,266,956 while market cap is $1,956, producing distorted price multiples. Key ratios: current ratio 2.12, debt/equity 0.91, and operating cash flow per share 0.34 (USD). These figures suggest operating cash generation but also highlight valuation distortions caused by the collapsed share price.

Meyka AI stock grade and technical read

Meyka AI rates NRTSF with a score out of 100: 67.20 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Technically, reported indicators show negligible trading breadth and an RSI flagged at 100.00, reflecting the extreme data point rather than normal momentum. Readers should note grades are informational and not investment advice.

Liquidity, trading risk and sector context

Liquidity is the primary short-term risk: average daily volume 31,802 vs today’s 657 means blocks will move the tape. The Healthcare sector (Medical – Care Facilities) had muted performance today, which did not drive the NRTSF move; this decline appears idiosyncratic. With such low market cap and a high enterprise value to EBITDA ratio distortions, stop-losses and position sizing are critical if entering a speculative trade.

Risks, catalysts and what to watch next

Immediate catalysts to monitor: OTC or PNK exchange notices, SEC filings or issuer statements, and any corporate action (reverse split, suspension, or delisting). Risks include further quotation adjustments, thin liquidity amplifying volatility, and potential regulatory outcomes. Positive catalysts would be corrective filings, confirmation of normal trading status, or a credible operational update from Nobilis Health Corp. (CEO Patrick Yoder).

Final Thoughts

NRTSF stock’s collapse to $2.50e-05 on 07 Mar 2026 is a classic microcap risk event: tiny market cap ($1,956), thin liquidity (657 shares), and a dramatic gap from prior close ($0.08041094) require investors to proceed with caution. Meyka AI’s forecast model projects a near-term reference level of $0.00010, implying an implied upside of +300.00% versus the current quote; forecasts are model-based projections and not guarantees. Given the company’s trailing EPS 0.02, book value per share 2.54, and an enterprise value that appears inconsistent with market cap, the path to any recovery likely needs clear corporate communications or a structural market event. For traders, the immediate checklist is simple: verify filings, confirm exchange status, and treat any position as speculative. Meyka AI’s analysis and grade provide context but are not a substitute for primary-source due diligence.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.